Day: March 11, 2021
FDA Approves Fotivda for Kidney Cancer
- March 11, 2021
- 0
- Category:
- Tags: Treatment Innovation
According Aveo Oncology, The Food and Drug Administration (FDA) on 10th March 2021 approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced kidney cancer (renal cell...
Read